KellieSpragueMD(She/Her)

Hematology • Portland, ME

Hematologic Oncology

Director, Hematologic Malignancies Program

Join to view full profile

Dr. Sprague is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sprague's full profile

Already have an account?

Office
MaineHealth Cancer Care/Maine Medical Center
Suite 2
Portland, ME 04106
Phone+1 207-661-0200
Is this information wrong?

Summary

Dr. Kellie Sprague is a hematologist in Portland, ME and is affiliated with Maine Medical Center. She received her medical degree from University of Vermont College of Medicine and has been in practice 26 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myeloproliferative disorders, myelodysplasia, and myelofibrosis.

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Tufts Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Vermont College of MedicineClass of 1991

Certifications & Licensure

ME State Medical License 2020 - 2024
MA State Medical License 1997 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Boston Magazine Castle Connolly, 2010-2020

Clinical Trials

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies Start of enrollment: 2006 Jul 01
Completed
Phase 2
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01
Terminated
Phase 2
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis Start of enrollment: 2013 Jan 01
Completed
Phase 2
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia Start of enrollment: 2019 Dec 06
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402...
Francine M. Foss, Xin Victoria Wang, Selina M. Luger, Opeyemi Jegede, Kenneth B. Miller, Edward A. Stadtmauer, Theresa L. Whiteside, David Avigan, Randall D. Gascoyne,...> ;Transfusion. 2020 Jul 12
8 citations
Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematolo...
Chakra P Chaulagain, Kellie Sprague, Monika Pilichowska, Janet M. Cowan, Andreas K. Klein, Esha Kaul, Kenneth B. Miller> ;Bone Marrow Transplantation. 2019 Apr 1
13 citations
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P Chaulagain, Parul Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa Warner, Kenneth B. Miller, ...> ;Experimental Hematology & Oncology. 2018 Oct 16
3 citations
Clustered incidence of adult acute promyelocytic leukemia.
Andrew M. Brunner, Peter Geon Kim, Hossein Sadrzadeh, Benjamin J. Drapkin, Kellie Sprague, J. Mark Sloan, Wanxing Chai-Ho, Parul Bhargava, Olga Pozdnyakova, Amir T. Fathi> ;Leukemia Research. 2018 Sep 19
4 citations
Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy
Sandy W. Wong, Denise Larivee, Melissa Warner, Kellie Sprague, Terry Fogaren, Raymond L. Comenzo> ;Bone Marrow Transplantation. 2017 Apr 10
3 citations
Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.
Gunjan L. Shah, Aaron N. Winn, Pei-Jung Lin, Andreas K. Klein, Kellie Sprague, Hedy Smith, Rachel J. Buchsbaum, Joshua T. Cohen, Kenneth B. Miller, Raymond L. Comenzo,...> ;Bone Marrow Research. 2016 Oct 18
28 citations
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Resul...
Gunjan L. Shah, Aaron N. Winn, Pei-Jung Lin, Andreas K. Klein, Kellie Sprague, Hedy Smith, Rachel J. Buchsbaum, Joshua T. Cohen, Kenneth B. Miller, Raymond L. Comenzo,...> ;Biology of Blood and Marrow Transplantation. 2015 Oct 1
14 citations
Bortezomib subcutaneous injection in combination regimens for myeloma or systemic light-chain amyloidosis: a retrospective chart review of response rates and toxicity ...
Gunjan L. Shah, Esha Kaul, Shelly Fallo, Furha I. Cossor, Hedy Smith, Kellie Sprague, Andreas K. Klein, Kenneth B. Miller, Raymond L. Comenzo> ;Clinical Therapeutics. 2013 Oct 1
37 citations
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
Hans G. Klingemann, Carrie Grodman, Elliott Cutler, Marvin Duque, Diane Kadidlo, Andreas K. Klein, Kellie Sprague, Kenneth B. Miller, Raymond L. Comenzo, Tarun Kewalra...> ;Transfusion. 2013 Feb 1
52 citations
Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.
Katie O'Callaghan, Lydia Lee, Nga Nguyen, Mo-Ying Hsieh, Nicole C. Kaneider, Andreas K. Klein, Kellie Sprague, Richard A. Van Etten, Athan Kuliopulos, Lidija Covic> ;Blood. 2012 Feb 16
23 citations
A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.
Andreas K. Klein, Kenneth B. Miller, Kellie Sprague, Jeffrey A. DesJardin, David R. Snydman> ;Bone Marrow Transplantation. 2011 Feb 1
2 citations
AIDS-related Burkitt lymphoma--a heterogeneous disease?
Alexey V. Danilov, Monika Pilichowska, Olga V. Danilova, Kellie Sprague> ;Leukemia Research. 2008 Dec 1
167 citations
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-contr...
Drew J. Winston, Jo Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, E.A. Vance, George Alangaden, Roy R. Chemaly, Finn Bo Petersen, Nelson J. Chao,...> ;Blood. 2008 Jun 1
147 citations
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and surv...
Francine M. Foss, Gina DiVenuti, Kevin M. Chin, Kellie Sprague, H Grodman, Andreas K. Klein, Geoffrey W. Chan, K Stiffler, Kenneth B. Miller> ;Bone Marrow Transplantation. 2005 Jun 1
54 citations
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Kenneth B. Miller, T. F. Roberts, G. Chan, David P. Schenkein, D. Lawrence, Kellie Sprague, Gullu Gorgun, Valerie Relias, H. Grodman, Anita Mahajan, Francine M. Foss> ;Bone Marrow Transplantation. 2004 May 1
23 citations
Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease.
Geoffrey W. Chan, Francine M. Foss, Andreas K. Klein, Kellie Sprague, Kenneth B. Miller> ;Biology of Blood and Marrow Transplantation. 2003 Dec 1
121 citations
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation
Uma Narayanasami, Rajani Kanteti, Julie Morelli, Alanna Klekar, Asma Al-Olama, Claire Keating, Colleen O'Connor, Eugene M. Berkman, John K. Erban, Kellie Sprague, Kenn...> ;Blood. 2001 Oct 1
86 citations
Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease.
Thierry Alcindor, Gullu Gorgun, Kenneth B. Miller, Todd F. Roberts, Kellie Sprague, David P. Schenkein, Francine M. Foss> ;Blood. 2001 Sep 1
20 citations
Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction
Todd F. Roberts, Kellie Sprague, David P. Schenkein, Kenneth B. Miller, Valerie Relias> ;Blood. 2000 Dec 1
72 citations
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
Yener Koc, Kenneth B. Miller, David P. Schenkein, Philip R. Daoust, Kellie Sprague, Eugene M. Berkman> ;Cancer. 1999 Feb 1
Join now to see all

Journal Articles

Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...
Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature
Prospective Study of Extracoporeal Photopheresis in Steroid-refractory or Steroid-resistant Extensive Chronic Graft-versus-Host-Disease: Analysis of Response & Surviva...
Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffer K. Miller KB, Bone Marrow Transplantation
Immunomodulatory Effects of Extracoporeal Photopheresis in Patients with Extensive Chronic Graft-Versus-Host-Disease
Alcindor T, Gorgun G, Miller KB, Roberts TF, Sprague K, Schenkein DP, Foss FM, Blood
Randomized Trial of Filgrastim versus Chemotherapy and Filgrastim Mobilization of Hematopoietic Progenitor Cells for Rescue in Autologous Transplantation
Narayanasami U, Kanteri R, Morelli J, Klekar A, Al-Olama A, Keating C, O'Connor C, Bermkan E, Erban JK, Sprague KA, Miller KB, Schenkein DP, Blood
Hyperleukocytosis during Induction Therapy with Arsenic Trioxide for Relased Acute Promyelocytic Leukemia associated with Central Nervous System Infarction
Robert TF, Sprague K, Schenkein DP, Relais V, Miller KB, Blood
A randomized, double-blinded, placebo-controlled trial of valacyclovir prophylaxis to prevent herpes zoster recurrence from months 4 to 24 months after BMT
Klein A, Miller KB, Sprague K, Desjardin JA, Snydman DR, Bone Marrow Transplantation
Join now to see all